Impact of pretransplant co-morbidities on non-relapse mortality and quality of life after allogeneic haematopoietic cell transplantation

被引：0
|
作者：
Nakaya, A. [1 ]
Mori, T. [1 ]
Aisa, Y. [1 ]
Yamazaki, R. [1 ]
Mihara, A. [1 ]
Ikeda, Y. [1 ]
Okamoto, S. [1 ]
机构：
[1] Keio Univ, Sch Med, Tokyo, Japan
来源：
BONE MARROW TRANSPLANTATION | 2007年 / 39卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S47 / S47
页数：1
相关论文
共 50 条
  • [1] Late non-relapse mortality after allogeneic hematopoietic cell transplantation: the impact of bronchiolitis obliterans
    Ozdemir Kumbasar, O
    Arat, M
    Beksac, M
    Ilhan, O
    Alper, D
    Koc, H
    BONE MARROW TRANSPLANTATION, 2002, 29 : S215 - S215
  • [2] Non-Relapse Mortality and Quality of Life with Shared Care after Allogeneic Hematopoietic Cell Transplantation: A Randomized Control Trial
    Abel, Gregory A.
    Kim, Haesook T.
    Zackon, Ira
    Alyea, Edwin P., III
    Bailey, Alexandra
    Winters, John P.
    Meehan, Kenneth R.
    Reagan, John L.
    Walsh, Jeanna
    Faggen, Meredith
    Sinclair, Sarah
    Joyce, Amy
    Close, Sara
    Emmert, Amy
    Kallassy, Isabella
    Koreth, John
    Antin, Joseph H.
    Cutler, Corey
    Ho, Vincent T.
    Soiffer, Robert J.
    BLOOD, 2022, 140 : 2135 - 2136
  • [3] Pretransplant serum FT3 levels in recipients predict early non-relapse mortality after myeloablative allogeneic haematopoietic cell transplantation from matched sibling donors
    Li, Huijuan
    Chen, Jia
    Shi, Bimin
    Chen, Xingbo
    Wu, Depei
    Wang, Ying
    HEMATOLOGY, 2018, 23 (01) : 38 - 43
  • [4] The impact of individual comorbidities on non-relapse mortality following allogeneic hematopoietic stem cell transplantation
    Joshua A. Fein
    Avichai Shimoni
    Myriam Labopin
    Noga Shem-Tov
    Ronit Yerushalmi
    Hila Magen
    Nadav Furie
    Eli Kopel
    Ivetta Danylesko
    Arnon Nagler
    Roni Shouval
    Leukemia, 2018, 32 : 1787 - 1794
  • [5] IMPACT OF REDUCTION IN GVHD-RELATED MORTALITY FOR RECENT IMPROVEMENT OF NON-RELAPSE MORTALITY AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION
    Kurosawa, S.
    Yakushijin, K.
    Yamaguchi, T.
    Atsuta, Y.
    Nagamura-Inoue, T.
    Akiyama, H.
    Taniguchi, S.
    Miyamura, K.
    Takahashi, S.
    Eto, T.
    Morishima, Y.
    Sakamaki, H.
    Fukuda, T.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S288 - S289
  • [6] Prediction of Non-Relapse Mortality with Dynamic Easix Scores after Allogeneic Hematopoietic Cell Transplantation
    Nawas, Mariam T.
    Sanchez-Escamilla, Miriam
    Devlin, Sean M.
    Maloy, Molly A.
    Perales, Miguel
    Giralt, Sergio A.
    Scordo, Michael
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S189 - S190
  • [7] The impact of individual comorbidities on non-relapse mortality following allogeneic hematopoietic stem cell transplantation
    Fein, Joshua A.
    Shimoni, Avichai
    Labopin, Myriam
    Shem-Tov, Noga
    Yerushalmi, Ronit
    Magen, Hila
    Furie, Nadav
    Kopel, Eli
    Danylesko, Ivetta
    Nagler, Arnon
    Shouval, Roni
    LEUKEMIA, 2018, 32 (08) : 1787 - 1794
  • [8] The Simplified Comorbidity Index predicts non-relapse mortality in reduced-intensity conditioning allogeneic haematopoietic cell transplantation
    Elias, Shlomo
    Brown, Samantha
    Devlin, Sean M.
    Barker, Juliet N.
    Cho, Christina
    Chung, David J.
    Dahi, Parastoo B.
    Giralt, Sergio
    Gyurkocza, Boglarka
    Jakubowski, Ann A.
    Lahoud, Oscar B.
    Landau, Heather
    Lin, Richard J.
    Papadopoulos, Esperanza B.
    Politikos, Ioannis
    Ponce, Doris M.
    Scordo, Michael
    Shaffer, Brian C.
    Shah, Gunjan L.
    Tamari, Roni
    Young, James W.
    Perales, Miguel-Angel
    Shouval, Roni
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 203 (05) : 840 - 851
  • [9] IMPACT OF PATIENT WEIGHT ON NON-RELAPSE MORTALITY AFTER MARROW TRANSPLANTATION
    DEEG, HJ
    SEIDEL, K
    BRUEMMER, B
    PEPE, MS
    APPELBAUM, FR
    BONE MARROW TRANSPLANTATION, 1995, 15 (03) : 461 - 468
  • [10] MINOR ABO MISMATCH IS ASSOCIATED WITH INCREASED NON-RELAPSE MORTALITY AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION
    Alimoghaddam, K.
    Logan, A. C.
    Wong, R.
    Weiss, S.
    Fontaine, M.
    Arai, S.
    Grumet, C.
    Miklos, D.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S285 - S286
12345